Highlights
KLSE: AHEALTH (7090)       APEX HEALTHCARE BHD MAIN : Consumer
Last Price Today's Change   Day's Range   Trading Volume
5.00   +0.06 (1.21%)  4.95 - 5.04  9,800
Analyze this stock with MQ Trader system

Overview

Market Cap: 586 Million
NOSH: 117 Million
Avg Volume (4 weeks):61,435
4 Weeks Range:4.94 - 5.48
4 Weeks Price Volatility (%):
11.11%
52 Weeks Range:4.49 - 5.80
52 Weeks Price Volatility (%):
38.93%
Average Price Target: 6.01
Price Target Upside/Downside: +1.01

Financial Highlight

Latest Quarter | Ann. Date 30-Sep-2017[#3]  |  14-Nov-2017
Next QR | Est. Ann. Date: 31-Dec-2017  |  23-Feb-2018
T4Q P/E | EY: 15.25  |  6.56%
T4Q DY | Payout %: 2.30%  |  35.06%
T4Q NAPS | P/NAPS: 2.82  |  1.77
T4Q NP Margin | ROE: 6.29%  |  11.63%

Headlines

Date Subject
20-Feb-2018 下跌股:Apex保健RM4.83支撑
26-Nov-2017 艾柏士保健增产后.盈利料更强劲
22-Nov-2017 Apex Heathcare Berhad - Positive Outlook
15-Nov-2017 Apex Healthcare (BUY, Maintain) - Solid 3Q17
15-Nov-2017 Mplus Market Pulse - 15 Nov 2017
15-Nov-2017 Apex Heathcare Berhad - 9MFY17 Above Expectations
31-Oct-2017 Apex - Ready for Next Phase of Growth
17-Aug-2017 业绩符预期.艾柏士保健具3优势
17-Aug-2017 APEX HEALTHCARE - 2QFY17 In Line
16-Aug-2017 APEX HEALTHCARE - Steady Growth
27-Apr-2017 Valunomics: Apex Healthcare Berhad

Business Background

Apex Healthcare Berhad (APEX) is a Malaysia-based company engaged in investment holding and the provision of management services. APEX operates in two segments: manufacturing of pharmaceutical products, and marketing, distribution and retailing of pharmaceutical products. APEX distributes its products under the brand names of XepaSP, AVEX, KAPS and PURE HEALTH, as well as medicated powder under the brand name ofAGNESIA. APEX is also engaged in property rental and management, as well as licensing of Apex Pharmacy trademark. Through its associated company, Xiamen Maidiken Science & Technology Co Ltd (MDK), APEX operates 67 retail pharmacy chains in Fujian province, the People's Republic of China. During the year ended December 31, 2009, AVEX products launched by APEX were Avevasc (Amlodipine), Ciprox (Ciprofloxacin), Herpevex (Acyclovir), Prazovex (Alprazolam) and Tramox (Tramadol). As of December 31, 2009, APEX had eight subsidiaries.
Analyze this stock with MQ Trader system

  3 people like this.
 
L. C. Chong AHEALTH analysis - http://lcchong.wordpress.com/2014/03/09/ahealthfundamental-analysis-9-mar-2014/
09/03/2014 18:44
L. C. Chong I may looking into Kossan and Supermx in the future.
09/03/2014 18:44
pang72 Need to park somemoney to those resilent grow stock
31/03/2014 20:10
L. C. Chong AHEALTH - http://lcchong.wordpress.com/2014/04/30/ahealthfundamental-analysis-30-apr-2014/
30/04/2014 13:31
L. C. Chong AHEALTH Analysis - http://lcchong.wordpress.com/2014/05/22/ahealthfundamental-analysis-21-may-2014/
22/05/2014 00:02
Abudance Wow! Drop so much! When is bonus entitlement received??
26/06/2014 13:43
Kitty28 Sorry, long time didnt come here already. What happened to Ahealth? Why dropped so much?
30/06/2014 14:47
chloe1990 y drop so much?somebody can tell?
25/07/2014 09:41
L. C. Chong AHEALTH analysis - https://lcchong.wordpress.com/2014/08/24/ahealth-fundamental-analysis-24-aug-2014/
24/08/2014 09:21
Ahmad Muzamil Ahmad Murad Waa this counter is very chun la.......... good dividend.
20/10/2014 18:43
logitrader http://www.klse.my/stock/insider/director/all/7090.jsp
25/12/2014 16:25
Abudance Good dividend then why drop 24 sen today?
02/01/2015 16:58
logitrader http://www.klse.my/entitlement/115919.jsp
25/02/2015 23:18
logitrader http://www.klse.my/financial/quarterResult/YoY/quarter/7090/31-Dec-2014.jsp
25/02/2015 23:24
kkteng70 Logotrader. I am new in understanding Financial result. Quarter 4 ended 31/12/2014 mean from (Dec14- Feb 15) or (Aug 14 - Nov 14). Which 3 months, they report on 25 Feb 15 ?
26/02/2015 13:11
mfed12 Quarter 4 ended 31/12/2014 mean from Oct-Dec 2014 which they report in Feb 2015..Quarter 1 (Q1)-Jan-Mar ..Q2-Apr-Jun..Q3- Jul-Sep..
e.g For Q1 ended 31 Mar 2015 usually the financial report in May 2015..
03/03/2015 09:41
kkteng70 Thanks, Mfed12...
18/03/2015 13:26
logitrader http://www.klse.my/financial/annualReport/7090/31-Dec-2014.jsp
29/04/2015 17:49
Hk Wong Apex Healthcare Berhad has strong business growth and is run by
efficient management. The trend in Apex Healthcare Berhad fair value
exchange rate against its closest peer, Ajinomoto (Malaysia) Berhad, Apex Healthcare Berhad shows similar undervaluation and is equally likely to outperform the market.
13/05/2015 08:01
Up_down Rotation play. Ahealth is the cheapest stock in pharmaceutical industry in term of PER.
23/07/2015 15:53
Up_down Here are the PER of pharmaceutical companies:

Ahealth - 15x
Biohdg - 18x
Caring - 22x
CCMdbio - 22x
Hovid - 23x
Kotra - 37x
Pharma - 18x
YSPsah - 21.5x
23/07/2015 15:59
Up_down This is a very illiquid stock. Big players can push up the price easily. Good to know that Stockraider has included Ahealth in his portfolio. He put this counter in the growth stock category.
26/07/2015 19:15
Up_down So far Stockraider has been doing well in recommending growth stocks. Yspsah jumped by 55% in less than 2 months. Superlon increased by 23% within one month. I believe that Ahealth would follow suit in near future.
26/07/2015 19:47
tjhldg yupsssssssss
03/08/2015 22:28
Hk Wong DOWN
06/11/2015 15:21
hairi Why down frm yesterday? Anyone knows?
06/11/2015 15:55
Invbeginner Up again
06/11/2015 16:00
Y2016 Very illiquid
21/01/2016 00:03
Koon Bee Dj --440
21/01/2016 00:04
Hk Wong result is similar to 2014. got dividend. market is still in down mode.
26/02/2016 08:31
Hk Wong net cash flow from operations is lower than 2014
26/02/2016 08:33
Hk Wong but anyway is good result overall.
27/02/2016 11:20
leehualoon Why drop so much?
23/03/2016 19:22
Smart Investor Can load more tomorrow....
23/03/2016 21:05
Smart Investor Shark create panic attack?
23/03/2016 21:23
Hk Wong 4.00
28/04/2016 15:20
cksiow Why drop so much?
20/08/2016 23:23
feiloh Why up so much
30/09/2016 16:07
value_trading Do ur guy notice the main share holder is buying this stock at 4.8? Million unit being purchase
18/01/2017 14:39
value_trading Please drop more, i will load more and buying at a cheaper price than the main share holder!!! LOL
19/01/2017 13:49
riderblack strong!
17/02/2017 14:15
value_trading oh, yes. Finally drop so that i can buy more.
Waiting for good quater result for the price to fly
Notice that shareholder bought a lots at the price of 4.60

Ahealth - 15x
Biohdg - 18x
Caring - 22x
CCMdbio - 22x
Hovid - 23x
Kotra - 37x
Pharma - 18x
YSPsah - 21.5x
20/02/2017 16:40
riderblack compare with anothers, Ahealth -15x still cheep
20/02/2017 17:07
Sid Di Hakimilokovich this is long history family business..when you cough, every clinic will give u the same ubat batok..that is their product..the creative work of a lifetime..
20/03/2017 15:42
Mark Goh VALUNOMICS:
Valuation at MYR 4.06 completed as of today 27 April 2017 with latest Annual Report. I cannot recommend a buy.

Read more here: https://klse.i3investor.com/blogs/Valunomics/121562.jsp
27/04/2017 16:51
shpg22 Yspsah 2.98 @ 12.9x. Where u get 21.5x ?
Cheapest pharma company in term of valuation still Yspsah. In my opinion, Ahealth is not cheap, slow growth and its very low volume, easily manipulated by major shareholder.
16/08/2017 11:41
Hk Wong Apex Healthcare Bhd (AHB) is an off-patent pharmaceutical company and third-party drug distributor with operations in Singapore,
Malaysia, Vietnam and Indonesia. Its fundamentals are underpinned by exciting future opportunities, higher margins as the contribution
from its own-brand products expands, and its compelling dividends.
18/08/2017 10:34
ironmania Good prospect for long term..can look into it..fundamental ..
01/12/2017 09:30
Hafid Do you think can go.lower oikr RM3.70
01/12/2017 14:57
Hafid Ringgit going up.
10/12/2017 21:27


 

423  175  537  765 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SUMATEC 0.080.00 
 HIBISCS 0.995+0.015 
 HIBISCS-CC 0.085+0.005 
 DGB 0.165+0.01 
 HUAAN 0.575+0.01 
 HSI-H2W 0.265-0.04 
 PDZ-WB 0.0450.00 
 SAPNRG 0.6950.00 
 LCTITAN-CG 0.045+0.015 
 UMWOG 0.335+0.005 
Partners & Brokers